Radical resection of a soft tissue tumor (e.g., sarcoma) of the pelvis and hip area measuring 5 cm or greater, including removal of surrounding tissue margins.
Verified May 8, 2026 · 7 sources ↓
- Medicare
- $1,643.66
- Total RVUs
- 49.21
- Global, days
- 90
- Region
- Hip
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 7 cited references ↓
- Tumor size documented as 5 cm or greater — measured at greatest dimension in operative or pathology report
- Anatomic location specified as pelvis and/or hip area, not generically described
- Operative note describes radical (wide-margin) resection, not simple excision or debulking
- Histologic or pathologic confirmation of tissue type (e.g., sarcoma, malignant neoplasm) tied to ICD-10 diagnosis
- If modifier 22 is appended, note must detail increased complexity: operative time, blood loss, proximity to neurovascular structures, or extent of tissue removal beyond standard
- Laterality documented when modifier LT or RT is used
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 7 cited references ↓
CPT 27059 covers radical resection of a soft tissue tumor — sarcoma being the prototypical example — in the pelvis and hip region when the lesion is 5 cm or larger. The procedure involves wide excision of the tumor mass along with a cuff of surrounding normal tissue; it is not a simple excision or debulking. Size is measured at the greatest dimension of the lesion as documented in the operative or pathology report.
The 90-day global period means all routine post-op care through day 90 is bundled. Complications requiring a return to the OR for a related procedure use modifier 78. Unrelated OR procedures in the same global window use modifier 79. If a separate, distinct procedure is performed at a different anatomic site on the same day, modifier 59 or XS applies — but document the distinct site explicitly; different diagnoses alone won't override NCCI bundling.
This code sits at the high end of orthopedic oncology RVU values, reflecting the complexity of the pelvic/hip anatomy, proximity to neurovascular structures, and the wide margins required. Laterality modifiers (LT/RT) apply when the tumor is clearly unilateral. Modifier 22 is appropriate when operative complexity substantially exceeds the typical case — but requires a supporting letter with operative time, blood loss, and specific anatomical obstacles documented in the note.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 28.62 |
| Practice expense RVU | 14.36 |
| Malpractice RVU | 6.23 |
| Total RVU | 49.21 |
| Medicare national rate | $1,643.66 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $1,643.66 |
HOPD (APC 5073) Hospital outpatient department | $2,967.63 |
ASC (PI G2) Ambulatory surgical center (freestanding) | $1,248.36 |
Common denial reasons
The recurring reasons claims for CPT 27059 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Tumor size not documented or measured in the operative/pathology report — payer downcodes to 27047 (less than 5 cm)
- ICD-10 diagnosis code does not support malignant or aggressive neoplasm of the pelvis/hip region, triggering medical necessity denial
- Modifier 22 appended without supporting documentation of unusual complexity — payer removes and reprices at base RVU
- Separate same-day procedure billed without modifier 59 or XS where NCCI bundling edits apply
- Missing or incomplete operative note — facility claim processes but professional claim denies for lack of documentation
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 7 cited references ↓
01What separates 27059 from 27047?
02Does 27059 require a malignant diagnosis to bill?
03Can you bill a biopsy code on the same day as 27059?
04When does modifier 22 apply to 27059?
05Is 27059 billed with LT or RT, and does modifier 50 ever apply?
06What global period applies and what does it include?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02vsac.nlm.nih.govhttps://vsac.nlm.nih.gov/context/cs/codesystem/CPT/version/2024/code/27059/info
- 03aapc.comhttps://www.aapc.com/codes/cpt-codes/27059
- 04findacode.comhttps://www.findacode.com/cpt/27059-cpt-code.html
- 05mdclarity.comhttps://www.mdclarity.com/cpt-code/27059
- 06cms.govhttps://www.cms.gov/files/document/mln1783722-proper-use-modifiers-59-xe-xp-xs-xu.pdf
- 07aapc.comhttps://www.aapc.com/blog/28071-understand-modifier-59-and-ncci-bundling/
Mira AI Scribe
Mira's AI scribe captures tumor size at greatest dimension, anatomic location within the pelvis or hip, resection margin description (wide, radical), proximity to neurovascular structures, estimated blood loss, and operative time — all from dictation. That prevents the most common denial: a payer downcode to 27047 because size or radical intent wasn't explicit in the note.
See how Mira captures CPT 27059 documentation